Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000902664-25-003536·HERON THERAPEUTICS, INC. /DE/
Schedule 13D ownership disclosure
HERON THERAPEUTICS, INC.
Common Stock, par value $0.01 per share · CUSIP: 427746102
Event date: 2025-08-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Rubric Capital Management LPReported CIK 0001687509
Shares: 29,100,728.00 · Class: 17.5%
- David RosenReported CIK 0001898677
Shares: 29,100,728.00 · Class: 17.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003536
- Form type
- SCHEDULE 13D/A
- Filer
- HERON THERAPEUTICS, INC. /DE/
- CIK
- CIK 818033
- Filed
- Aug 12, 2025
- Reporting period
- Aug 08, 2025
- Description
- Schedule 13D beneficial ownership